Justice Department, DEA propose more cuts to opioid drug manufacturing

The Times-Picayune - U.S. drug manufacturers may soon face tighter production quotas on six opioids that are prone to abuse. The limits, part of a proposal from the Trump administration, would reduce drug production by 10 percent over the next year.

The new limits are part of the Trump administration's "Safe Prescribing Plan," which seeks to decrease how much fentanyl, hydrocodone, hydromorphone, morphine, oxycodone and oxymorphone is produced in the country. The administration aims to cut production of those drugs by one-third over the next three years.